Targeting the insulin-like growth factor axis as a cancer therapy.
about
BMS-536924 reverses IGF-IR-induced transformation of mammary epithelial cells and causes growth inhibition and polarization of MCF7 cellsActivated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma.Molecular biological challenges in he treatment of esophageal adenocarcinoma.Elevated epithelial insulin-like growth factor expression is a risk factor for lung cancer development.
P2860
Targeting the insulin-like growth factor axis as a cancer therapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Targeting the insulin-like growth factor axis as a cancer therapy.
@ast
Targeting the insulin-like growth factor axis as a cancer therapy.
@en
type
label
Targeting the insulin-like growth factor axis as a cancer therapy.
@ast
Targeting the insulin-like growth factor axis as a cancer therapy.
@en
prefLabel
Targeting the insulin-like growth factor axis as a cancer therapy.
@ast
Targeting the insulin-like growth factor axis as a cancer therapy.
@en
P2860
P356
P1433
P1476
Targeting the insulin-like growth factor axis as a cancer therapy
@en
P2093
Tufia Haddad
P2860
P304
P356
10.2217/14796694.2.1.101
P407
P50
P577
2006-02-01T00:00:00Z